| Date | Title | Description | Source |
| 19.02.2024 | Neurophth Announces Completion of Patient Enrollment for Opv... | WUHAN, China and SAN DIEGO, Feb. 19, 2024 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurop... | en.prnasia... |
| 17.08.2023 | Neurophth Announces First Patient Dosed in Phase I/II Clinic... | WUHAN, China and SAN DIEGO, Aug. 17, 2023 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurop... | en.prnasia... |
| 14.08.2023 | Deals in brief: Binance Labs backs two DeFi protocols, AHG L... | Binance Labs invests USD 15 million over two new deals with DeFi protocols
The venture capital and i... | kr-asia.co... |
| 11.08.2023 | Neurophth Secures Nearly 95 Million USD in Series C+ Financi... | WUHAN, China and SAN DIEGO, Aug. 11, 2023 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurop... | en.prnasia... |
| 11.08.2023 | Neurophth Raises Nearly USD95M in Series C+ Financing | Neurophth Therapeutics, a Wuhan, China-based gene therapy company for ophthalmic diseases, raised ne... | finsmes.co... |
| 10.08.2023 | Deals in brief: Meatable secures USD 35 million in funding, ... | Meatable raises USD 35 million in its latest funding round
The Netherlands-based food tech company h... | kr-asia.co... |
| 21.02.2023 | Commercialization of Gene Therapy is coming soon: Neurophth ... | WUHAN, China and SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurop... | en.prnasia... |
| 19.12.2022 | Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene T... | WUHAN, China and SAN DIEGO, Dec. 19, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurop... | en.prnasia... |
| 27.09.2022 | Neurophth announces first patient dosed in Phase III clinica... | WUHAN, China and SAN DIEGO, Sept. 27, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neuro... | en.prnasia... |
| 15.07.2022 | China CDE Grants Breakthrough Therapy Designation (BTD) to N... | WUHAN, China and SAN DIEGO, July 15, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc., ("Neuro... | en.prnasia... |
| 07.06.2022 | The 3rd BIO International Convention 2022 is Approaching | SAN DIEGO, June 7, 2022 /PRNewswire/ -- With the 3rd BIO International Convention 2022 soon approach... | en.prnasia... |
| 02.06.2022 | Neurophth Therapeutics Appoints Xiaoning Guo as Chief Medica... | SHANGHAI and SAN DIEGO, June 2, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc., (hereinafter refe... | en.prnasia... |
| 25.01.2022 | Neurophth Therapeutics' Treatment of Leber's Hereditary Opti... | WUHAN, China and SAN DIEGO, Jan. 25, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc., (hereinafter... | en.prnasia... |
| 19.01.2022 | Neurophth Therapeutics Receives IND Clearance to Initiate Cl... | WUHAN, China and SAN DIEGO, Jan. 19, 2022 /PRNewswire/ -- Neurophth Therapeutics, Inc., (hereinafter... | en.prnasia... |
| 24.11.2021 | Neurophth Therapeutics Strengthens Leadership Team with Appo... | SHANGHAI and SAN DIEGO, Nov. 24, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrat... | en.prnasia... |
| 23.11.2021 | Neurophth Raised Over $60 Million USD in Series-C Financing ... | SAN DIEGO, Nov. 23, 2021 /PRNewswire/ -- Neurophth Therapeutics Ltd., ("Neurophth"), a ful... | en.prnasia... |
| 23.11.2021 | Hedge fund Alden Global wants to sink its teeth into another... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 23.11.2021 | Hedge fund Alden Global wants to sink its teeth into another... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 23.11.2021 |
Neurophth Gains $60M For Gene Therapy Efforts
| San Diego-based Neurophth, a gene therapy company, has raised $60M in a Series C funding round, the ... | socaltech.... |
| 23.11.2021 | Neurophth Therapeutics Raises USD60M in Series C Funding | Neurophth Therapeutics, a Wuhan, Shanghai, and Suzhou, China- and San Diego CA-based integrated geno... | finsmes.co... |
| 27.09.2021 | Neurophth Announces the Completion of GMP Manufacturing Faci... | WUHAN, China and SAN DIEGO, Sept. 27, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-int... | en.prnasia... |
| 19.08.2021 | Neurophth Expands Its Global Gene Therapy Leadership Team wi... | WUHAN, China and SAN DIEGO, Aug. 19, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-inte... | en.prnasia... |
| 19.08.2021 | Neurophth Expands Its Global Gene Therapy Leadership Team wi... | | prnewswire... |
| 28.06.2021 | First in China! Neurophth announced the first patient has be... | Novel and one-time intravitreal injection of ND4 gene therapy for the treatment of LHON potentially ... | en.prnasia... |
| 01.06.2021 | Neurophth Therapeutics and Hopstem Biotechnology Announce St... | HOUSTON and SAN DIEGO, June 1, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrated... | en.prnasia... |
| 09.02.2021 | Neurophth Closes $61.9 Million Series B Financing | Neurophth Biotechnology Ltd., a fully-integrated genetic medicines company developing AAV-delivered ... | citybizlis... |
| 09.02.2021 | Neurophth Closes RMB 400M Series B Financing | Neurophth Biotechnology Ltd., a Wuhan, China-based fully-integrated genetic medicines company develo... | finsmes.co... |
| 27.01.2021 | Neurophth Therapeutics Further Expands Ocular Gene Therapy E... | WUHAN, China and NEWARK, Del., Jan. 27, 2021 /PRNewswire/ — Wuhan Neurophth Biotechnology Ltd., a fu... | oaoa.com/l... |
| - | Neurophth Therapeutics | “纽福生物生物、纽福斯、Ophthalmology-based Treatment,neurophth” | fastfounde... |
